These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 31730913)
1. Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes. Kim G; Kim M; Lee Y; Byun JW; Hwang DW; Lee M J Control Release; 2020 Jan; 317():273-281. PubMed ID: 31730913 [TBL] [Abstract][Full Text] [Related]
2. Delivery of High Mobility Group Box-1 siRNA Using Brain-Targeting Exosomes for Ischemic Stroke Therapy. Kim M; Kim G; Hwang DW; Lee M J Biomed Nanotechnol; 2019 Dec; 15(12):2401-2412. PubMed ID: 31748020 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia-specific anti-RAGE exosomes for nose-to-brain delivery of anti-miR-181a oligonucleotide in an ischemic stroke model. Kim M; Lee Y; Lee M Nanoscale; 2021 Sep; 13(33):14166-14178. PubMed ID: 34477698 [TBL] [Abstract][Full Text] [Related]
4. Antisense-oligonucleotide co-micelles with tumor targeting peptides elicit therapeutic effects by inhibiting microRNA-21 in the glioblastoma animal models. Lee Y; Ha J; Kim M; Kang S; Kang M; Lee M J Adv Res; 2023 Nov; 53():249-260. PubMed ID: 36632887 [TBL] [Abstract][Full Text] [Related]
5. Brain-targeted exosome-mimetic cell membrane nanovesicles with therapeutic oligonucleotides elicit anti-tumor effects in glioblastoma animal models. Lee Y; Kim M; Ha J; Lee M Bioeng Transl Med; 2023 Mar; 8(2):e10426. PubMed ID: 36925699 [TBL] [Abstract][Full Text] [Related]
6. T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma. Li C; Guan N; Liu F J Neurooncol; 2023 Mar; 162(1):93-108. PubMed ID: 36854924 [TBL] [Abstract][Full Text] [Related]
7. Engineering exosomes for pulmonary delivery of peptides and drugs to inflammatory lung cells by inhalation. Kim G; Lee Y; Ha J; Han S; Lee M J Control Release; 2021 Feb; 330():684-695. PubMed ID: 33388343 [TBL] [Abstract][Full Text] [Related]
8. Anti-cancer effect of R3V6 peptide-mediated delivery of an anti-microRNA-21 antisense-oligodeoxynucleotide in a glioblastoma animal model. Oh B; Song H; Lee D; Oh J; Kim G; Ihm SH; Lee M J Drug Target; 2017 Feb; 25(2):132-139. PubMed ID: 27355932 [TBL] [Abstract][Full Text] [Related]
9. Engineered exosomes mediated targeted delivery of neuroprotective peptide NR2B9c for the treatment of traumatic brain injury. Haroon K; Zheng H; Wu S; Liu Z; Tang Y; Yang GY; Liu Y; Zhang Z Int J Pharm; 2024 Jan; 649():123656. PubMed ID: 38040392 [TBL] [Abstract][Full Text] [Related]
10. Kill two birds with one stone: Engineered exosome-mediated delivery of cholesterol modified YY1-siRNA enhances chemoradiotherapy sensitivity of glioblastoma. Liu X; Cao Z; Liu N; Gao G; Du M; Wang Y; Cheng B; Zhu M; Jia B; Pan L; Zhang W; Jiang Y; He W; Xu L; Zhang W; An Q; Guo Q; Gu J Front Pharmacol; 2022; 13():975291. PubMed ID: 36059990 [TBL] [Abstract][Full Text] [Related]
11. Delivery of anti-microRNA-21 antisense-oligodeoxynucleotide using amphiphilic peptides for glioblastoma gene therapy. Song H; Oh B; Choi M; Oh J; Lee M J Drug Target; 2015 May; 23(4):360-70. PubMed ID: 25572456 [TBL] [Abstract][Full Text] [Related]
12. Cardiac-specific delivery by cardiac tissue-targeting peptide-expressing exosomes. Kim H; Yun N; Mun D; Kang JY; Lee SH; Park H; Park H; Joung B Biochem Biophys Res Commun; 2018 May; 499(4):803-808. PubMed ID: 29621543 [TBL] [Abstract][Full Text] [Related]
13. A curcumin-loaded polymeric micelle as a carrier of a microRNA-21 antisense-oligonucleotide for enhanced anti-tumor effects in a glioblastoma animal model. Tan X; Kim G; Lee D; Oh J; Kim M; Piao C; Lee J; Lee MS; Jeong JH; Lee M Biomater Sci; 2018 Jan; 6(2):407-417. PubMed ID: 29340361 [TBL] [Abstract][Full Text] [Related]
14. Targeted Delivery of Nanoparticle-Conveyed Neutrophils to the Glioblastoma Site for Efficient Therapy. Piao C; Lee J; Kim GE; Choe YH; Lee H; Hyun YM ACS Appl Mater Interfaces; 2024 Aug; 16(32):41819-41827. PubMed ID: 39057192 [TBL] [Abstract][Full Text] [Related]
15. Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells. Zhu L; Oh JM; Gangadaran P; Kalimuthu S; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC Front Immunol; 2018; 9():824. PubMed ID: 29740437 [TBL] [Abstract][Full Text] [Related]
16. Delivery of Anti-miRNA-221 for Colorectal Carcinoma Therapy Using Modified Cord Blood Mesenchymal Stem Cells-Derived Exosomes. Han S; Li G; Jia M; Zhao Y; He C; Huang M; Jiang L; Wu M; Yang J; Ji X; Liu X; Chen C; Chu X Front Mol Biosci; 2021; 8():743013. PubMed ID: 34616773 [No Abstract] [Full Text] [Related]
17. Exosome-Mediated miR-29 Transfer Reduces Muscle Atrophy and Kidney Fibrosis in Mice. Wang H; Wang B; Zhang A; Hassounah F; Seow Y; Wood M; Ma F; Klein JD; Price SR; Wang XH Mol Ther; 2019 Mar; 27(3):571-583. PubMed ID: 30711446 [TBL] [Abstract][Full Text] [Related]
18. RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer's disease. Cui GH; Guo HD; Li H; Zhai Y; Gong ZB; Wu J; Liu JS; Dong YR; Hou SX; Liu JR Immun Ageing; 2019; 16():10. PubMed ID: 31114624 [TBL] [Abstract][Full Text] [Related]
19. Exosomes of bone-marrow stromal cells inhibit cardiomyocyte apoptosis under ischemic and hypoxic conditions via miR-486-5p targeting the PTEN/PI3K/AKT signaling pathway. Sun XH; Wang X; Zhang Y; Hui J Thromb Res; 2019 May; 177():23-32. PubMed ID: 30844685 [TBL] [Abstract][Full Text] [Related]
20. Enhanced brain-targeting and efficacy of cannabidiol via RVG-Exo/CBD nanodelivery system. Li Y; Chen Z; Guo J; Meng D; Pang X; Sun Z; Pu L; Yang S; Yang M; Peng Y Biochem Biophys Res Commun; 2024 Sep; 725():150260. PubMed ID: 38878760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]